VICTORIA BATES: Open Payments
NPI 1710316062 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,352 in 272 payments from 18 companies in 2025. Trend: 2023 $3,397 · 2024 $4,064 · 2025 $4,352
Food & beverage: $4,245Education: $107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $539 |
| Janssen Biotech, Inc. | 25 | $446 |
| LEO Pharma Inc. | 25 | $442 |
| Incyte Corporation | 17 | $359 |
| PFIZER INC. | 44 | $335 |
| Galderma Laboratories, L.P. | 22 | $305 |
| GENZYME CORPORATION | 9 | $298 |
| Regeneron Healthcare Solutions, Inc. | 10 | $279 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $238 |
| Novartis Pharmaceuticals Corporation | 11 | $236 |
Products named: DUPIXENT, TREMFYA, ADBRY, OPZELURA, SKYRIZI, CIBINQO, NEMLUVIO, RINVOQ.
Industry payments across IN — which companies pay providers there.
